Researchers at the University of Gothenburg, Sweden, have linked immune-system cells that react to a certain bacteria in stomach ulcers to a risk factor for developing stomach cancer.

Oral bisphosphonates, a treatment for bone disease, may double the risk of developing esophageal cancer (cancer of the gullet), according to a new study from the University of Oxford.